DDS used in current medical practice

Numerous new medications have been developed to effectively treat complicated conditions, but at the same time some of them produce severe side effects that the benefit does not always outweigh the risk. Some drugs have been proven to be very effective in vitro but cannot withstand the endogenous enzymes found within the gastrointestinal (GI) tract (if taken orally), deeming them nearly worthless in vivo. While incredible progress has been made in identifying drug targets, designing and making better drug molecules; there is still room to improve the drug delivery systems and targeting


  • Track 1-1 Controlled DDS in clinical disease management
  • Track 2-2 Current research in drug delivery
  • Track 3-3 Nanoparticles in the clinic
  • Track 4-4 Challenges of liposome assisted drug delivery
  • Track 5-5 Implantable drug delivery
  • Track 6-6 Drug delivery for brain tumour

Related Conference of Pharmaceutical Sciences